Opinion

Video

Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.

Video content above is prompted by the following question(s):

  • Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?
Related Videos
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo